drugset
Drugs / pSG2.HIVconsv DNA
last change Aug 2015 re-read 2 minutes ago

pSG2.HIVconsv DNA

Vaccine

Developed for
AIDS
Investigated by
European and Developing Countries Clinical Trials Partnership (EDCTP) · Ichor Medical Systems Incorporated · International AIDS Vaccine Initiative · Karolinska Institutet · University of Nairobi · University of Oxford

Trials 1 · a red edge is where a trial was stopped

today NCT02099994 · Ph 1/2
20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT02099994 Mar 2014 → Aug 2015 AIDS University of Oxford Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as pSG2.HIVconsv DNA ClinicalTrials.gov intervention name — accepted as the source's own label NCT02099994 ↗
Modality Vaccine “The vaccines used are pSG2.HIVconsv DNA (D), MVA.HIVconsv (M) and Ad35-GRIN (A)” NCT02099994 ↗